Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms.

Sci Rep 2019 12 13;9(1):19123. Epub 2019 Dec 13.

New York Genome Center, New York, NY, 10013, USA.

To test the performance of a new sequencing platform, develop an updated somatic calling pipeline and establish a reference for future benchmarking experiments, we performed whole-genome sequencing of 3 common cancer cell lines (COLO-829, HCC-1143 and HCC-1187) along with their matched normal cell lines to great sequencing depths (up to 278x coverage) on both Illumina HiSeqX and NovaSeq sequencing instruments. Somatic calling was generally consistent between the two platforms despite minor differences at the read level. We designed and implemented a novel pipeline for the analysis of tumor-normal samples, using multiple variant callers. We show that coupled with a high-confidence filtering strategy, the use of combination of tools improves the accuracy of somatic variant calling. We also demonstrate the utility of the dataset by creating an artificial purity ladder to evaluate the somatic pipeline and benchmark methods for estimating purity and ploidy from tumor-normal pairs. The data and results of the pipeline are made accessible to the cancer genomics community.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-55636-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911065PMC
December 2019

Publication Analysis

Top Keywords

cell lines
12
somatic calling
8
whole-genome sequencing
8
cancer cell
8
sequencing
6
hiseqx novaseq
4
ladder evaluate
4
illumina hiseqx
4
evaluate somatic
4
novaseq sequencing
4
calling generally
4
purity ladder
4
instruments somatic
4
coverage illumina
4
sequencing instruments
4
somatic variant
4
coupled high-confidence
4
lines great
4
great sequencing
4
benchmark methods
4

Altmetric Statistics

Similar Publications